Arctoris is an Oxford-based biotechnology and artificial intelligence company that has developed a platform to be used for the research and development of drugs for diseases such as cancer. The platform is used in industries such as biotechnology, pharmaceuticals, academia, and artificial intelligence drug discovery.
The platform allows for researchers to design their experiment with an online configurator and also gives them access to a team of experts prior the initiation of the experiment. Arctoris then has its own robotics perform the experiments remotely as per the researchers' specifications. Researchers can see the results of the experiment in real-time using the platform.
The platform works with in silico drug discovery and provides a range of assays and techniques. The company offers services for both cell-based assays and target-based assays.During the COVID-19 pandemic, Arctoris offered services such as biochemical profiling, molecular assays, and its cellular assays.
Kilian R. Dinkelaker
Co-Founder and CFO
Co-Founder and CEO
Co-Founder and COO
Arctoris announces partnership with Molecule to tackle the innovation crisis in drug discovery and development
February 10, 2020
Arctoris Ltd Secures Seed Funding of £3.2 Million to Advance Novel Drug Discovery Platform Powered by Robotics
September 30, 2019